AcaRevival Initiative

Experienced academic misconduct or bullying? We're building a real weapon against it.

Read Manifesto →
SG

Sarah F. Gurev

Massachusetts Institute of Technology

No ratings yetBe the first to rate
Loading...

About Sarah F. Gurev at Massachusetts Institute of Technology (MIT)

Sarah F. Gurev is a researcher based at Massachusetts Institute of Technology. They specialize in Cancer Research and Treatments, Virus-based gene therapy research, and CAR-T cell therapy research, with ongoing contributions to these areas. Their research has drawn over 266 citations, marking them as an increasingly recognized voice in their field. A solid H-index of 5 speaks to the quality and reach of their work.

Research Areas

Cancer Research and TreatmentsVirus-based gene therapy researchCAR-T cell therapy researchImmunotherapy and Immune ResponsesRNA Interference and Gene Delivery

Academic Impact Matrix

Research output metrics for Sarah F. Gurev aggregated from public academic databases. Student lab experience data is pending.

Academic data verified · April 2026 · Next sync: May 2026

Research Output

Total Citations266

Emerging researcher

Publications96

Selective publication record

h-index5

Developing track record

i10-index5

Early-stage portfolio

Lab Environment

No lab data yet for Sarah F. Gurev

+ Contribute First Review
  • Supervisionawaiting data
  • Responsivenessawaiting data
  • Fundingawaiting data
  • Communicationawaiting data
  • Work-Life Balanceawaiting data

Top Publications

Reviews (0)

No reviews yet for this supervisor.

Be the first to share your experience!

Is your PI driving you crazy?

Featured Article

The Sunday Night Dread: Surviving a Micromanaging PhD Supervisor

Real advice from PhD students on recognizing and navigating difficult supervisor relationships

Your experience matters. After reading the guide, share your review to help other PhD students.

Frequently Asked Questions

Not sure how to interpret mixed signals? A structured decision guide can help you think through high-risk supervision choices more clearly. Download the free guide.